Part of IMA Clinical Research's nationwide site network and is located in the one of the fastest growing cities in the United States. This site has a proven track record of collaborating with the world’s top pharmaceutical companies and CROs. The PI’s specialize in a diverse range of research areas, including NASH/NAFLD, Type 2 Diabetes, GERD, Asthma, Acne, Hypertension, COVID-19 vaccine, Osteoarthritis, Lupus, Renal disease, Heart disease, COVID-19 treatment, and more. With their extensive experience and expertise, we’re equipped to handle even the most complex and challenging clinical trials.

IMA Clinical Research partners in the development of new medical treatments through a flexible, full-service clinical trial site network that provides extensive patient access and diversity. IMA Clinical Research provides a comprehensive network of clinical research sites and an array of over one hundred and eighty satellite locations, providing extensive, nationwide patient access. Furthermore, we have a rapidly growing database of over 400,000 patients and the ability to reach millions.

We a modern, tech-enabled operating model to deliver various study designs, including classic site-based, hybrid and fully decentralized trials. We established the Patient Outreach Center to connect with patients who aren’t typically seen onsite, promoting longitudinal engagement, improving data collection and bolstering patient retention. Coupled with centralized contracting and rigorous regulatory adherence, IMA Clinical Research is uniquely positioned to deliver quick startup and high-quality studies across the network.